Pharma Company That Makes Jatenzo Sued

[Jinzang]

Clarus, the pharmaceutical company that makes Jatenzo, a recently introduced oral formulation of testosterone, has been sued by Lipocine, the company that makes Tlando, a rival oral formulation candidate, for patent violations. Tlando has been denied approval for sale three times by the FDA, but Lipocine has applied again for approval. The trial is set to begin August 24, 2020.

The information is from this financial news article.

 

[Nelson Vergel]

Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio

- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years - JATENZO is an oral softgel...

www.prnewswire.com